Skip to content

    HPV/Genital Warts Health Center

    Font Size
    A
    A
    A

    HPV Vaccine Gardasil OK'd for Boys

    FDA Approves Gardasil to Help Prevent Genital Warts in Boys and Young Men
    By
    WebMD Health News
    Reviewed by Louise Chang, MD

    Oct. 16, 2009 -- The FDA has approved the vaccine Gardasil to help prevent genital warts in boys and young men.

    Gardasil is now approved for males ages 9 to 26 for the prevention of genital warts caused by two human papillomavirus (HPV) strains: HPV 6 and HPV 11.Those are two of the four HPV strains that Gardasil targets.

    In September, an FDA advisory panel recommended Gardasil's approval to prevent genital warts in boys and young men. The vaccine wasn't up for consideration to help prevent cancer in males or to curb transmission of the HPV virus, which is sexually transmitted, to women.

    Gardasil is not yet on the CDC's schedule of recommended vaccines for males. The CDC's Advisory Committee on Immunization Practices will discuss that possibility at a meeting next week.

    Gardasil, which is made by the drug company Merck, already has FDA approval for use in girls and young women ages 9 to 26. In females, HPV can cause cervical cancer.

    Today on WebMD

    HPV Vaccine Future
    Article
    STD Overview
    Slideshow
     
    STD Facts Quiz
    Quiz
    Syringes and graph illustration
    Tool
     
    Sex Drive Killers
    Slideshow
    Genital Herpes Risks Quiz
    Quiz
     
    Young couple holding hands
    Quiz
    Herpes Vaccine Study
    Video
     
    Condom Quiz
    Quiz
    HPV Symptoms Tests
    Article
     
    Get The STD Picture
    Feature
    cancer cell
    Slideshow
     

    WebMD Special Sections